Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calin

Showing results (701-710 of 748) with videos related to

Pageof 75
Sort By:
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Cancer Letters|April 6, 2025
KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPABShumei Song, Yibo Fan, Gengyi Zou, et al.
Blood Cancer Journal|October 22, 2024
The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemiaRonghua Zhang, Priyanka Khare, Priyanka Banerjee, et al.
Cancer Discovery|September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatmentMasato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
Nature|February 14, 2020
Loss of p53 drives neuron reprogramming in head and neck cancerMoran Amit, Hideaki Takahashi, Mihnea Paul Dragomir, et al.
Cancer Cell|September 6, 2007
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomasGeorge A Calin, Chang-gong Liu, Manuela Ferracin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Oncogene|September 22, 2019
GLS2 is protumorigenic in breast cancersMarilia M Dias, Douglas Adamoski, Larissa M Dos Reis, et al.
Ebiomedicine|August 20, 2015
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall SurvivalAlessandra Ferrajoli, Cristina Ivan, Maria Ciccone, et al.
Nature Communications|October 18, 2017
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3pJonathan Berrout, Eleni Kyriakopoulou, Lavanya Moparthi, et al.
Pageof 75

Showing results (701-710 of 748) with videos related to

Sort By:
Pageof 75
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Cancer Letters|April 6, 2025
KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPABShumei Song, Yibo Fan, Gengyi Zou, et al.
Blood Cancer Journal|October 22, 2024
The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemiaRonghua Zhang, Priyanka Khare, Priyanka Banerjee, et al.
Cancer Discovery|September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatmentMasato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
Nature|February 14, 2020
Loss of p53 drives neuron reprogramming in head and neck cancerMoran Amit, Hideaki Takahashi, Mihnea Paul Dragomir, et al.
Cancer Cell|September 6, 2007
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomasGeorge A Calin, Chang-gong Liu, Manuela Ferracin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2024
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primaryAndrea Cavazzoni, Irene Salamon, Claudia Fumarola, et al.
Oncogene|September 22, 2019
GLS2 is protumorigenic in breast cancersMarilia M Dias, Douglas Adamoski, Larissa M Dos Reis, et al.
Ebiomedicine|August 20, 2015
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall SurvivalAlessandra Ferrajoli, Cristina Ivan, Maria Ciccone, et al.
Nature Communications|October 18, 2017
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3pJonathan Berrout, Eleni Kyriakopoulou, Lavanya Moparthi, et al.
Pageof 75